Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Talibegron hydrochloride is an β3 adrenergic receptor agonist with a pD2 of 3.72 on phenylephrine-preconstricted rat mesenteric artery. Relaxes rat mesenteric artery and isolated aorta in vitro. Inhibits ob gene expression and circulating leptin levels in lean mice in vivo.
Description | Talibegron hydrochloride is an β3 adrenergic receptor agonist with a pD2 of 3.72 on phenylephrine-preconstricted rat mesenteric artery. Relaxes rat mesenteric artery and isolated aorta in vitro. Inhibits ob gene expression and circulating leptin levels in lean mice in vivo. |
In vitro | Talibegron hydrochloride ( 0.01-1000 μM) produces a concentration-dependent relaxation of phenylephrine-preconstricted isolated mesenteric arteries and causes full relaxation with 1 mM[1]. |
In vivo | The β3-adrenoceptor agonist talibegron hydrochloride produced a concentration-dependent relaxation of phenylephrine-preconstricted isolated mesenteric arteries. The shape of the concentration–response curve of talibegron hydrochloride also suggests that this drug, which was studied up to 1 mm, causes full relaxation [3]. |
Synonyms | ZD2079 hydrochloride |
Molecular Weight | 351.83 |
Formula | C18H22ClNO4 |
CAS No. | 178600-17-4 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
H2O: <8.8mg/ml
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Talibegron hydrochloride 178600-17-4 GPCR/G Protein Neuroscience Adrenergic Receptor ZD2079 hydrochloride Inhibitor inhibitor inhibit